Alpha lipoic acid (ALA) regenerates glutathione back to its active form
Those considering peptides for recovery should weigh the benefits against safety concerns, consult medical supervision, and continue proven therapies such as physical therapy, rest, and nutrition
According to NICE guidance, GLP-1 receptor agonists are recommended for specific patient groups with type 2 diabetes (NG28) and, in some formulations like Wegovy (semaglutide 2.4mg) and Saxenda (liraglutide 3mg), for weight management in adults with obesity or overweight with weight-related comorbidities
Additionally, species-specific variations in GLP-1 receptor structure and expression complicate direct extrapolation across preclinical models, thereby increasing uncertainty in cross-system interpretation
Regular check-ins : Book a consultation to track changes and intervene early if needed